BeOne Medicines ONC
NASDAQ ONC
$358.74 -3.94 (-1.09%)
As of: Sep 4, 2026 · 12:49 PM EDT

BeOne Medicines (ONC) EPS (Diluted) (2016 - 2026)

Analysis

BeOne Medicines (ONC) EPS (Diluted) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 12.23
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 7.15
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.05 Bn 44.05 Bn - -3.06
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.52 Bn 27.68 Bn - 0.15
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -0.06
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn 2.81
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.05
Mar 31, 2026 1.96
Dec 31, 2025 0.59
Sep 30, 2025 1.09
Jun 30, 2025 0.84
Mar 31, 2025 0.01
Dec 31, 2024 -1.44
Sep 30, 2024 -1.15
Jun 30, 2024 -1.15
Mar 31, 2024 -2.41
Dec 31, 2023 -3.52
Sep 30, 2023 2.01
Jun 30, 2023 -3.64
Mar 31, 2023 -3.34
Dec 31, 2022 -4.32
Sep 30, 2022 -5.39
Jun 30, 2022 -5.50
Mar 31, 2022 -4.25
Dec 31, 2021 -6.37
Sep 30, 2021 -4.72